- Reinstein ZZ, Zhang Y, Ospina OE, Nichols MD, Chu VA, Pulido AM, Prieto K, Nguyen JV, Yin R, Moran Segura C et al. Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy. Cancer Discov 2024 Sep 04;14(9):1631-1652. doi:10.1158/2159-8290.CD-23-0798
- Law C, Wacleche VS, Cao Y, Pillai A, Sowerby J, Hancock B, Horisberger A, Bracero S, Skidanova V, Li Z et al. Publisher Correction: Interferon subverts an AHR-JUN axis to promote CXCL13+ T cells in lupus. Nature 2024 Aug;632(8025):E6. doi:10.1038/s41586-024-07845-8
- Garcia J, Daniels J, Lee Y, Zhu I, Cheng K, Liu Q, Goodman D, Burnett C, Law C, Thienpont C et al. Naturally occurring T cell mutations enhance engineered T cell therapies. Nature 2024 Feb;626(7999):626-634. doi:10.1038/s41586-024-07018-7
-
Wartewig T, Daniels J, Schulz M, Hameister E, Joshi A, Park J, Morrish E, Venkatasubramani AV, Cernilogar FM, van Heijster FHA et al. PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma. Nat Cancer 2023 Oct;4(10):1508-1525. doi:10.1038/s43018-023-00635-7